Pinnacle Associates’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Pinnacle Associates’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-162,625	Closed	-$15.8M	–	749
2019 Q3	$15.8M	Sell	162,625 -9,360	-5%	-$937K	0.37%	74
2019 Q2	$17.6M	Sell	171,985 -17,121	-9%	-$1.85M	0.41%	64
2019 Q1	$21.5M	Sell	189,106 -8,883	-4%	-$653K	0.49%	55
2018 Q4	$7.75M	Sell	197,989 -2,676	-1%	-$116K	0.2%	135
2018 Q3	$10.9M	Sell	200,665 -6,860	-3%	-$469K	0.23%	120
2018 Q2	$17.2M	Sell	207,525 -26,905	-11%	-$2.08M	0.35%	83
2018 Q1	$15.6M	Buy	+234,430	New	+$13.5M	0.31%	92

Pinnacle Associates's ONCE Position: Q4 2019 in Review

Pinnacle Associates sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 162,625 shares — an estimated $15.8M sold.

Pinnacle Associates first reported a position in ONCE in Q1 2018 and held it in 7 quarters. The position peaked at $21.5M in Q1 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

Pinnacle Associates reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Pinnacle Associates sold 162,625 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $15.8M.
Pinnacle Associates first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2018 and held it in 7 quarters.
Pinnacle Associates's Spark Therapeutics, Inc. Common Stock position peaked at $21.5M in Q1 2019.
0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Pinnacle Associates's 13F filing for Q4 2019, filed 3 Feb 2020.